Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.555
+0.055 (10.90%)
At close: Mar 9, 2026, 4:00 PM EDT
0.550
-0.005 (-0.97%)
After-hours: Mar 9, 2026, 7:13 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $128.53 million as of March 9, 2026. Its market cap has decreased by -62.93% in one year.
Market Cap
128.53M
Enterprise Value
151.18M
1-Year Change
-62.93%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $128.53M, a decrease of -87.09%. That is a compound annual growth rate of -25.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 127.37M |
| Alpha Cognition | 125.89M |
| Black Diamond Therapeutics | 122.50M |
| Genelux | 120.01M |
| Inovio Pharmaceuticals | 119.54M |
| Gain Therapeutics | 117.31M |
| Oncolytics Biotech | 114.06M |
| Coya Therapeutics | 112.31M |